Literature DB >> 475166

Reproducibility of hemoglobin AIc and sensitivity to various degrees of glucose intolerance.

P J Dunn, R A Cole, J S Soeldner, R E Gleason.   

Abstract

To establish a normal range of hemoglobin (Hb) AIc, and ascertain the sensitivity and reproducibility of this test, three groups were studied: patients with suspected diabetes undergoing a standard oral glucose tolerance test, diabetic outpatients, and subjects with normal carbohydrate tolerance studies on two separate occasions. In Group 1, the mean Hb AIc (+/- SD) in 165 carbohydrate-tolerant subjects was 4.97 +/- 0.50% and the normal range was the mean +/- 2 standard deviations (4.0 to 6.0%). The mean Hb AIc (+/- SD) of the 63 carbohydrate-intolerant subjects was 6.45 +/- 1.14, significantly greater than the normal subjects. In both subgroups, Hb AIc correlated significantly with the fasting blood glucose but not with the glucose areas of the oral glucose-tolerance test. In Group 2, the Hb AIc values were normal in 39% of those diet treated, 10% of those on oral agents, and none of those on insulin therapy. In Group 3, the mean coefficient of variation of the two Hb AIc values for each subject was 6.86% but was 7.15% for the fasting blood glucose. These findings suggest that Hb AIc is highly reproducible and responsive to minor degrees of abnormality of glucose tolerance and may provide an alternative method for defining carbohydrate tolerance or the degree of blood sugar control.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 475166     DOI: 10.7326/0003-4819-91-3-390

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  16 in total

1.  Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women.

Authors:  Aruna D Pradhan; Nader Rifai; Julie E Buring; Paul M Ridker
Journal:  Am J Med       Date:  2007-08       Impact factor: 4.965

2.  Pre-transplant HbA1c level as an early marker for new-onset diabetes after renal transplantation.

Authors:  Erhan Tatar; Fatih Kircelli; Meltem Sezis Demirci; Mehmet Nuri Turan; Ozkan Gungor; Gulay Asci; Mehmet Ozkahya; Ercan Ok; Cuneyt Hoscoskun; Huseyin Toz
Journal:  Int Urol Nephrol       Date:  2012-10-07       Impact factor: 2.370

Review 3.  Glycosylated haemoglobin: measurement and clinical use.

Authors:  I Peacock
Journal:  J Clin Pathol       Date:  1984-08       Impact factor: 3.411

4.  The relationship between glycosylated haemoglobin levels and various degrees of glucose intolerance.

Authors:  A Verrillo; A de Teresa; R Golia; V Nunziata
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

5.  Multivariate analysis of glycosylated haemoglobin in insulin-treated diabetics.

Authors:  D F Child; J Wood; P R Hudson; C P Williams; D R Roberts; C Smith
Journal:  J R Soc Med       Date:  1985-07       Impact factor: 5.344

6.  Clinical usefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus.

Authors:  J R Baker; J P O'Connor; P A Metcalf; M R Lawson; R N Johnson
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-24

7.  Glycosylated hemoglobin in endogenous hypertriglyceridemia.

Authors:  D Fedele; A Lapolla; C Cardone; G Baldo; G Crepaldi
Journal:  Acta Diabetol Lat       Date:  1983 Oct-Dec

8.  Glycosylated hemoglobin in patients treated by chronic dialysis.

Authors:  P Hirszel; M A Galen; T Happe; M Lasrich
Journal:  Int Urol Nephrol       Date:  1981       Impact factor: 2.370

9.  Epidemiological features of glycated haemoglobin A1c-distribution in a healthy population. The Telecom Study.

Authors:  D Simon; C Senan; P Garnier; M Saint-Paul; L Papoz
Journal:  Diabetologia       Date:  1989-12       Impact factor: 10.122

10.  OGTT 2-hour serum C-peptide index as a predictor of post-transplant diabetes mellitus in kidney transplant recipients.

Authors:  Xingqiang Lai; Lei Zhang; Jiali Fang; Guanghui Li; Lu Xu; Junjie Ma; Yunyi Xiong; Luhao Liu; Zheng Chen
Journal:  Ann Transl Med       Date:  2019-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.